← All TKR analyses

The Timken Company

TKR · Industrials
B ★★★ Hold
Aug 2, 2026 · Score 80 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $137.55
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $128.00 ($120.00–$135.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $160.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+16.3%

Type A - The Timken Company (TKR) 20260802 Stock Analysis

📅 Timken Key Upcoming Events

🏢 Step 1: Timken Company Overview & Business Model

Q1-A1. What is Timken?

Q1-A2. How Does Timken Make Money?

Q1-A3. Timken’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Timken’s Competitors?

Q1-A5. Timken Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Timken’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Timken Have a Durable Economic Moat?

Q2-A2. Is Timken’s Growth Sustainable?

Q2-A3. How Does Timken Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Timken Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Timken? (Margins & ROIC)

Q3-A3. What Drives Timken’s Returns? (ROIC Breakdown)

Q3-A4. Are Timken’s Earnings High Quality?

Q3-A5. Is Timken’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Timken Forensic Accounting & Dilution Review

Q4-A1. Does Timken Have Accounting Red Flags?

Q4-A2. Is Timken Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Timken’s Cash Flow?

Q4-A4. Is Timken Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Timken Management & Shareholder Alignment

Q5-A1. Can You Trust Timken’s Management? (Guidance Track Record)

Q5-A2. What Are Timken Insiders Doing?

Q5-A3. Is Timken’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Timken Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Timken Guidance

Q6-A2. What Is Timken’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Timken Catalysts & Price Triggers

Q7-A1. What Could Move Timken Stock? (Top 3 Catalysts)

Q7-A2. Timken’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Timken Fairly Valued? Valuation Analysis

Q8-A1. Timken’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Timken vs Peers: Valuation Comparison

Q8-A3. Is Timken Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Timken? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Timken? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Timken’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Timken? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Timken?

Q9-A2. How Sensitive Is Timken to the Economy?

Q9-A3. Timken Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Timken Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Timken? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Timken’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Timken’s Heavy Reliance on the Engineered Bearings Segment Its Biggest Weakness?

Q2: Can Timken’s 22.9x Forward P/E Be Justified by the Industrial Automation Supercycle?

Q3: Will the Aggressive Chinese Expansion by ZWZ and LYC Destroy Timken’s Wind Energy Margins?

Q4: How Severe is the Impact of Section 232 Tariffs on Timken’s Cost Structure?

Q5: Is the “80/20” Strategy a Genuine Margin Catalyst or Just Corporate Buzzword Bingo?

Q6: Can Timken Maintain its 13-Year Streak of Dividend Increases While Funding Aggressive M&A?

Q7: Did the Executive Turmoil of 2025 Permanently Damage Institutional Trust in Timken?

Q8: How Vulnerable is the Medical Robotics Pivot to Hospital CapEx Freezes?

Q9: Will the Bijur Delimon Acquisition Actually Deliver Meaningful Synergies?

Q10: Are the 2028 “Elevate to Outperform” Financial Targets Actually Achievable?